Cargando…
Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer’s Disease Progression
Total tau (t-tau) and phosphorylated tau (p-tau) protein elevations in cerebrospinal fluid (CFS) are well-established hallmarks of Alzheimer’s disease (AD), while the associations of serum t-tau and p-tau levels with AD have been inconsistent across studies. To identify more accessible non-invasive...
Autores principales: | Nam, Eunjoo, Lee, Yeong-Bae, Moon, Cheil, Chang, Keun-A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404390/ https://www.ncbi.nlm.nih.gov/pubmed/32679907 http://dx.doi.org/10.3390/ijms21145007 |
Ejemplares similares
-
Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease
por: Jung, Da Hae, et al.
Publicado: (2022) -
Blood-based immunoassay of tau proteins for early diagnosis of Alzheimer's disease using surface plasmon resonance fiber sensors
por: Vu Nu, Truong Thi, et al.
Publicado: (2018) -
The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017) -
miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease
por: Park, Hyunjun, et al.
Publicado: (2022) -
Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer’s disease
por: Yoo, Seung-Jun, et al.
Publicado: (2020)